Akseli Hemminki Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
REPL | F | Replimune Group, Inc. | 4.39 | |
CLDI | F | Calidi Biotherapeutics, Inc. | 0.44 |
Related Industries: Biotechnology
Related Stock Lists:
Biotechnology
Cancer
Oncolytic Virus
Solid Tumors
Virotherapy
Cancer Immunotherapy
Cancer Treatment
Cell Biology
Cell Therapy
Clinical Medicine
Experimental Cancer Treatments
Glioma
Immune System
Immunotherapy
Immunotherapy Products
Medicine
Metastatic Disease
Rp1
Stem Cell
Transgene Sa
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | D | Loncar Cancer Immunotherapy ETF | 1.01 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 0.7 | |
XBI | D | SPDR S&P Biotech ETF | 0.51 | |
ILDR | C | First Trust Innovation Leaders ETF | 0.36 | |
LABU | F | Direxion Daily S&P Biotech Bull 3X Shares | 0.36 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 23 | CLDI | Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24 |
Related Industries:
Biotechnology
Related Stock Lists:
Biotechnology
Cancer
Oncolytic Virus
Solid Tumors
Virotherapy
Cancer Immunotherapy
Cancer Treatment
Cell Biology
Cell Therapy
Clinical Medicine
Experimental Cancer Treatments
Glioma
Immune System
Immunotherapy
Immunotherapy Products
Medicine
Metastatic Disease
Rp1
Stem Cell
Transgene Sa
- Akseli Hemminki
Akseli Hemminki (1973-07-27) July 27, 1973 (Helsinki) is a Finnish specialist in Oncology and Radiotherapy, Professor of Oncology and founder of two biotechnology companies.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles